In association with NanHealth, Cancer Treatment Centers of America has partnered with Allscripts in a seamless workflow of accessing and utilizing electronic health records. The Clinical Pathways program is being used to produce more efficient methods of treating cancer in a tech advancement setting. The process is designed to let medical professionals access numerous data points, make observations, and determine a practical way of treating new patients via past treatment results. All the data is gathered from cancer care data compiled through medical professionals around the nation.
How is this possible? Up to date data allows professionals to better take care of patients through learning from past trials. In essence, the treatments are basically improving by evaluating prior experiences. The system is able to produce specific regimens for each patient which is available in real time to medical professionals. Clinical Pathways is improving quality and efficiency in treatment of cancer patients. One of the biggest benefits of utilizing the platform is that it holds the potential to expedite treatment. The sooner medical professionals can diagnose a problem and a solution for a patient the better. This time is truly invaluable in the treatment process.
A medical library is used to store treatment based evidence. This allows physicians to easily look up data, view it objectively, and go forward in accordance to their patient’s best interests. It is a peer to peer library that relies on the information of medical professionals all around the nation.
The CTCA is based in Boca Raton Florida and currently has 5 practices. These hospitals are in Tulsa, Phoenix, Philadelphia, Chicago and Atlanta. The CTCA is noted as providing high quality medical care in all it’s locations.
Each center seeks to employ highly qualified medical professionals able to produce effective methods of treatment. The utilized platform at the hospitals is able to aid employees in procuring the best possible medical treatments. All CTCA hospitals make use of the innovative Clinical Pathways platform for this reason.